MustGrow Biologics Statistics
Total Valuation
MGROF has a market cap or net worth of 40.49 million. The enterprise value is 38.71 million.
| Market Cap | 40.49M |
| Enterprise Value | 38.71M |
Important Dates
The last earnings date was Thursday, April 24, 2025.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +3.41% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 44.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 146.38 |
| PB Ratio | 26.85 |
| P/TBV Ratio | 36.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.39 |
| EV / Sales | 135.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.24.
| Current Ratio | 1.61 |
| Quick Ratio | 1.07 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -126.10% and return on invested capital (ROIC) is -62.46%.
| Return on Equity (ROE) | -126.10% |
| Return on Assets (ROA) | -45.66% |
| Return on Invested Capital (ROIC) | -62.46% |
| Return on Capital Employed (ROCE) | -179.09% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.71% in the last 52 weeks. The beta is 1.97, so MGROF's price volatility has been higher than the market average.
| Beta (5Y) | 1.97 |
| 52-Week Price Change | +5.71% |
| 50-Day Moving Average | 0.79 |
| 200-Day Moving Average | 0.90 |
| Relative Strength Index (RSI) | 56.35 |
| Average Volume (20 Days) | 1,078 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MGROF had revenue of 276,624 and -3.40 million in losses. Loss per share was -0.07.
| Revenue | 276,624 |
| Gross Profit | 55,943 |
| Operating Income | -3.14M |
| Pretax Income | -3.40M |
| Net Income | -3.40M |
| EBITDA | n/a |
| EBIT | -3.14M |
| Loss Per Share | -0.07 |
Balance Sheet
The company has 2.08 million in cash and 360,006 in debt, giving a net cash position of 1.72 million.
| Cash & Cash Equivalents | 2.08M |
| Total Debt | 360,006 |
| Net Cash | 1.72M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.51M |
| Book Value Per Share | 0.03 |
| Working Capital | 1.23M |
Cash Flow
| Operating Cash Flow | -2.49M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 20.22% |
| Operating Margin | -1,133.77% |
| Pretax Margin | -1,228.27% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MGROF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.41% |
| Shareholder Yield | -3.41% |
| Earnings Yield | -8.39% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MGROF has an Altman Z-Score of 1.8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.8 |
| Piotroski F-Score | n/a |